Sage Therapeutics, Inc.
A CRYSTALLINE 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID
Last updated:
Abstract:
This invention relates to a crystalline 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I), ##STR00001## and compositions thereof. Also disclosed herein are methods of making the same and methods of using the same.
Status:
Application
Type:
Utility
Filling date:
6 Aug 2021
Issue date:
2 Jun 2022